EP1751152A2 - Imidazoazines d'azinyle et carboxamides d'azinyle - Google Patents

Imidazoazines d'azinyle et carboxamides d'azinyle

Info

Publication number
EP1751152A2
EP1751152A2 EP05737913A EP05737913A EP1751152A2 EP 1751152 A2 EP1751152 A2 EP 1751152A2 EP 05737913 A EP05737913 A EP 05737913A EP 05737913 A EP05737913 A EP 05737913A EP 1751152 A2 EP1751152 A2 EP 1751152A2
Authority
EP
European Patent Office
Prior art keywords
methyl
optionally
cyano
alkyl
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05737913A
Other languages
German (de)
English (en)
Inventor
Hans-Georg Schwarz
Jens Frackenpohl
Achim Hense
Peter Lösel
Olga Malsam
Karl-Heinz Kuck
Gerhard Krautstrunk
Christian Arnold
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer CropScience AG
Original Assignee
Bayer CropScience AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer CropScience AG filed Critical Bayer CropScience AG
Publication of EP1751152A2 publication Critical patent/EP1751152A2/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/50—1,3-Diazoles; Hydrogenated 1,3-diazoles
    • A01N43/52—1,3-Diazoles; Hydrogenated 1,3-diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Definitions

  • the invention relates to azinyl-imidazoazines and their derivatives, processes for their preparation and their use as plant treatment agents, in particular for controlling animal pests and plant diseases.
  • the invention also relates to azinyl carboxamide intermediates for the preparation of the azinyl imidazoazines and the use of these compounds as plant treatment agents, in particular for controlling animal pests and plant diseases.
  • azinyl-triazoles, azinyl-oxadiazoles and azinyl-oxadiazinones and their possible use as pesticides, in particular as insecticides, are already known from the (patent) literature (cf. EP-A 185256, WO 01/14373, WO 02/12229 ). Further insecticidally active azinylearboxamides are known from JP-07010841, JP-07025853 and WO-02/022583.
  • a 1 , A 2 , A 3 , A 4 and A 5 are the same or different and each represent N (nitrogen) or the grouping CR, but the imidazoazine bicyclus in each case contains 2 to 5 N atoms and in none If more than two N atoms are adjacent, and where R in the CR groupings can in each case have the same or different meanings in accordance with the definition below,
  • R in each case stands for H (hydrogen), nitro, amino, cyano, halogen, or for optionally substituted alkyl, alkoxy, alkylthio, alkylsulfinyl, alkylsulfonyl, alkylamino or dialkylamino, or optionally two adjacent R groups together represent alkanediyl or together with the azine group to which they are attached form a benzene ring,
  • R 1 represents (C ⁇ -C -) haloalkyl
  • a 1 , A 2 , A 3 , A 4 and A 5 are the same or different and each preferably represents N (nitrogen) or the grouping CR, but the imidazoazine bicycles contain 2 to 5 N atoms and in no case more are adjacent as two N atoms, and where R in the CR groupings can in each case have the same or different meanings in accordance with the definition below.
  • R in each case preferably represents H (hydrogen), nitro, amino, cyano, halogen, or alkyl, alkoxy, alkylthio, alkylsulfinyl, alkylsulfonyl, alkylamino or dialkylamino, each of which is optionally substituted by cyano, halogen or C 1 -C 4 -alkoxy 6 carbon atoms in the alkyl groups, or optionally two adjacent R-grappings together represent alkanediyl having 3 to 5 carbon atoms, or, optionally, two adjacent R groups together with the azine group to which they are attached form a benzene ring.
  • R 1 preferably represents CF 3 , CH F or CF 2 C1.
  • a 1 , A 2 , A 3 , A 4 and A 5 are the same or different and each particularly preferably represents N (nitrogen) or the group CR, but the hnidazoazine bicyclic group contains 2 to 4 N atoms and where R in the groupings CR may in each case have the same or different meanings according to the definition below.
  • R in each case particularly preferably represents H (hydrogen), nitro, amino, cyano, fluorine, chlorine, bromine, iodine, or in each case optionally by cyano, fluorine, chlorine, bromine, methoxy, ethoxy, n- or i-propoxy, n -, i-, s- or t-butoxy substituted methyl, ethyl, n- or i-propyl, n-, i-, s- or t-butyl, methoxy, ethoxy, n- or i-propoxy, n-, i-, s- or t-butoxy, methylthio, ethylthio, n- or i-propylthio, n-, i-, s- or t-butylthio, methylsulfinyl, ethylsulfinyl, n- or i-propylsulfin
  • R * particularly preferably represents CF3.
  • Phenylsulfonylaminoiminomethyl Dimethylaminocarbonyl, diethylaminocarbonyl, dimethylaminosulfonyl, diethylaminosulfonyl, phenoxy or phenyl substituted phenyl, naphthyl, phenoxy, naphthyloxy, phenylthio, naphthylthio, phenylamino, naphthylamino, phenylaminoiminomethyl, Benzyl, phenylethyl, phenylpropyl, phenylethynyl, phenylmethoxy, phenylethoxy, propoxy phenyl, phenylmethylthio, phenylmethylamino, phenylethylamino, Phenylmethylamino- iminomethyl, or Phenylmethoxyiminomethyl Phenylsulfonylaminoiminomethyl, or represents in each
  • a 1 , A 2 , A 3 , A 4 and A 5 are the same or different and each very particularly preferably represents N (nitrogen) or the grouping CR, but the imidazoazine bicyclus contains 2 or 3 N atoms and where R may have the same or different meanings according to the definition below in the CR groups in individual cases.
  • R each very particularly preferably represents H (hydrogen), nitro, amino, cyano, fluorine, chlorine, bromine, iodine, or in each case optionally by cyano, fluorine, chlorine, bromine, methoxy, ethoxy, n- or i-propoxy, n-, i-, s- or t-butoxy substituted methyl, ethyl, n- or i-propyl, n-, i-, s- or t-butyl, methoxy, ethoxy, n- or i-propoxy, n- , i-, s- or t-butoxy, methylthio, ethylthio, n- or i-propylthio, n-, i-, s- or t-butylthio, methylsulfinyl, ethylsulfinyl, n- or i-propylsulfiny
  • R * very particularly preferably stands for CF3.
  • X very particularly preferably represents H (hydrogen), hydroxycarbonyl (COOH), aminocarbonyl optionally substituted by benzyloxycarbonyl, N, O-dimethylhydroxylaminocarbonyl, N, O-diethylhydroxylaminocarbonyl, N-methyl-O-ethylhydroxylaminocarbonyl or N-ethyl-O-methylhydroxylaminocarbonyl , for nitro, formyl, hydroximinomethyl, aminoiminomethyl, amino, cyano, fluorine, chlorine, bromine, iodine, for each optionally by cyano, hydroxy, fluorine, chlorine, methoxy, ethoxy, n- or i-propoxy, methylcarbonyloxy, ethylcarbonyloxy, dimethylaminocarbonyloxy , Methylamino, ethylamino, dimethylamino, diethylamino, dipropylamino, benzylamin
  • a very particularly preferred group are the compounds of the formula (IA)
  • R and X have the meanings and preferences given above or
  • R in each case the same or different, very particularly preferably for H (hydrogen), nitro, amino and cyano, fluorine, chlorine, bromine, iodine, or for in each case optionally by cyano, fluorine, chlorine, bromine, methoxy, ethoxy, n- or i -Propoxy substituted methyl, ethyl, n- or i-propyl, methoxy, ethoxy, n- or i-propoxy, methylthio, ethylthio, n- or i-propylthio, methylsulfonyl, ethylsulfinyl, methylsulfonyl, ethylsulfonyl, methylamino, ethylamino, n- or i-propylamino, dimethylamino or diethylamino, or in each case optionally two adjacent R groups together for propane-1,3-diyl
  • X very particularly preferably for H (hydrogen), nitro, formyl, hydroximinomethyl, amino, cyano, fluorine, chlorine, bromine, iodine, for each methyl optionally substituted by cyano, fluorine, chlorine, methoxy, ethoxy, n- or i-propoxy , Ethyl, n- or i-propyl, acetyl, propionyl, n- or i-butyroyl, methoxy, ethoxy, n- or i-propoxy, methoxycarbonyl, ethoxycarbonyl, n- or i-propoxycarbonyl, methoximinomethyl, ethoximino-methyl , Methylthio, ethylthio, n- or i-propylthio, methylsulfinyl, ethylsulfinyl, methylsulfonyl, ethylsul
  • Another very particularly preferred group are the compounds of the formula (TB)
  • R and X have the meanings and preferences given above or
  • R in each case the same or different, very particularly preferably for H (hydrogen), nitro, amino, cyano, fluorine, chlorine, bromine, iodine, or for each optionally by cyano, fluorine, chlorine, bromine, methoxy, ethoxy, n- or i -Propoxy substituted methyl, ethyl, n- or i-propyl, methoxy, ethoxy, n- or i-propoxy, methylthio, ethylthio, n- or i-propylthio, methylsulfinyl, ethylsulfinyl, methylsulfonyl, ethylsulfonyl, methylamino, ethylamino, n- or i-propylamino, dimethylamino or diethylamino, or in each case optionally two adjacent R groups together for propane-1,3-diyl, but
  • X very particularly preferably for H (hydrogen), nitro, formyl, hydroximinomethyl, amino, cyano, fluorine, chlorine, bromine, iodine, for each methyl optionally substituted by cyano, fluorine, chlorine, methoxy, ethoxy, n- or i-propoxy , Ethyl, n- or i-propyl, acetyl, propionyl, n- or i-butyroyl, methoxy, ethoxy, n- or i-propoxy, methoxy- carbonyl, ethoxycarbonyl, n- or i-propoxycarbonyl, mefhoximinomethyl, ethoximino-methyl, methylthio, ethylthio, n- or i-propylthio, methylsulfinyl, ethylsulfinyl, methylsulfonyl, ethylsulf
  • a 1 , A 2 , A 3 , A 4 and A 5 are the same or different and each preferably represents N (nitrogen) or the grouping CR, but the imidazoazine bicycles contain 2 to 5 N atoms and in no case more as two N atoms are adjacent, and where R in the CR groupings can in each case have the same or different meanings in accordance with the definition below.
  • R in each case preferably represents H (hydrogen), nitro, amino, cyano, halogen, or alkyl, alkoxy, alkylthio, alkylsulfinyl, alkylsulfonyl, alkylamino or dialkylamino, each of which is optionally substituted by cyano, halogen or C 1 -C 4 -alkoxy 6 carbon atoms in the alkyl groups, or optionally two adjacent R groups together represent alkanediyl having 3 to 5 carbon atoms, or optionally two adjacent R groups together with the azine group to which they are attached form a benzene ring.
  • R 1 preferably represents CF 3 , CH F 2 or CF 2 C1.
  • a 1 , A 2 , A 3 , A 4 and A 5 are the same or different and each particularly preferably represents N (nitrogen) or the grouping CR, but the imidazoazine bicyclus contains 2 to 4 N atoms and where R in the groupings CR may in each case have the same or different meanings according to the definition below.
  • R in each case particularly preferably represents H (hydrogen), nitro, amino, cyano, fluorine, chlorine, bromine, iodine, or in each case optionally by cyano, fluorine, chlorine, bromine, methoxy, ethoxy, n- or i-propoxy, n -, i-, s- or t-butoxy substituted methyl, ethyl, n- or i-propyl, n-, i-, s- or t-butyl, methoxy, ethoxy, n- or i-propoxy, n-, i-, s- or t-butoxy, methylthio, ethylthio, n- or i-propylthio, n-, i-, s- or t-butylthio, methylsulfinyl, ethylsulfinyl, n- or i-propylsulfin
  • Rl is preferably CF3.
  • a 1 , A 2 , A 3 , A 4 and A 5 are the same or different and each very particularly preferably represents N (nitrogen) or the grouping CR, but the imidazoazine bicyclus contains 2 or 3 N atoms and where R may have the same or different meanings according to the definition below in the CR groups in individual cases.
  • R each very particularly preferably represents H (hydrogen), nitro, amino, cyano, fluorine, chlorine, bromine, iodine, or in each case optionally by cyano, fluorine, chlorine, bromine, methoxy, ethoxy, n- or i-propoxy, n-, i-, s- or t-butoxy substituted methyl, ethyl, n- or i-propyl, n-, i-, s- or t-butyl, methoxy, ethoxy, n- or i-propoxy, n- , i-, s- or t-butoxy, methylthio, ethylthio, n- or i-propylthio, n-, i-, s- or t-butylthio, methylsulfinyl, ethylsulfinyl, n- or i-propylsulfiny
  • R 1 very particularly preferably represents CF3.
  • X very particularly preferably represents H (hydrogen), nitro, formyl, hydroximinomethyl, aminoiminomethyl, amino, cyano, NCO (isocyanato), NCS (isothiocyanato), fluorine, chlorine, bromine, iodine, each optionally by cyano, hydroxy, fluorine , Chlorine, methoxy, ethoxy, n- or i-propoxy substituted methyl, ethyl, n- or i-propyl, n-, i-, s- or t-butyl, acetyl, propionyl, n- or i-butyroyl, methoxy , Ethoxy, n- or i-propoxy, n-, i-, s- or t-butoxy, methoxycarbonyl, ethoxycarbonyl, n- or i-propoxycarbonyl, methoximinomethyl, ethoximinomethyl
  • a 1 , A 2 , A 3 , A 4 , A 5 , R, R 1 and X have the meaning given above,
  • condensation aids if appropriate in the presence of diluents
  • Formula (H) provides a general definition of the N-azinylalkyl-azinecarboxamides to be used as starting materials in the process according to the invention for the preparation of the compounds of the general formula (I).
  • a 1 , A 2 , B, X, Y 1 , Y 2 and Y 3 preferably or in particular those meanings which are already preferred in connection with the description of the compounds of the general formula (I) according to the invention or as particularly preferred for A 1 , A 2 , B, X, Y 1 , Y 2 and Y 3 have been specified.
  • the starting materials of the general formula (II) are 4-trifluoromethyl -N - [(5-tifluoromethyl-2-pyridinyl) methyl] pyridine-3-carboxamide, 4-trifluoromethyl-N - [(2,6-dichloro-4-pyridinyl) methyl] pyridine-3-carboxamide , 4-trifluoromethyl-N - [(6-chloro-2-pyridinyl) methyl] pyridine-3-carboxamide, 4-trifluoromethyl-N - [(2,3,5,6-tetrachloro-4-pyridinyl ) -methyl] -pyridine-3-carboxamide, 4-trifluoromethyl-N - [(2-pyridinyl
  • the compounds of the formula (TI) are, with the exception of the compounds N- (2-pyridinylmethyl) - 4-trifluoromethyl-pyridine-3-carboxamide (cf. JP-07010841 - cited in Chem. Abstracts 123: 32961), 4-trifluoromethyl N - [(5-ttifluoromethyl-2-pyridinyl) methyl] pyridine-3-carboxamide, 4-trifluoromethyl-N - [(2,6-dichloro-4-pyridinyl) methyl] pyridine-3- carboxamide, 4-trifluoromethyl-N - [(6-chloro-2-pyridinyl) methyl] pyridine-3-carboxamide, 4-trifluoromethyl-N - [(2,3,5,6-tetrachloro-4-pyridinyl) - methyl] -pyridine-3-carboxamide, 4-trifluo ⁇ nemyl-N - [(2-pyridinyl)
  • the heterocycle containing the substituents A 1 , A 2 , A 3 and A 4 contains one nitrogen atom less than the corresponding imidazoazine bicyclic compound in the end products.
  • the invention furthermore relates to the use of compounds of the formula (IT) as intermediates for the production of active agrochemicals, in particular insecticides and fungicides.
  • the compounds of the formula (ET) themselves are particularly suitable for controlling unwanted microorganisms in and / or on plants and / or animal pests.
  • the compounds are therefore particularly highly active insecticides.
  • a 1 , A 2 , A 3 and A 4 are the same or different and each represent N (nitrogen) or the grouping CR, but the heterocycle containing the substituents A 1 , A 2 , A 3 and A 4 in each case 2 or contains 3 N atoms and in no case is more than two N atoms adjacent, and where R in the CR groups in the individual cases can have the same or different meanings in accordance with the definition below, R in each case represents H (hydrogen), nitro, amino, cyano, halogen, or in each case optionally substituted alkyl, alkoxy, alkylthio, alkylsulfinyl, alkylsulfonyl, alkylamino or dialkylamino, or optionally two adjacent R groups together represent alkanediyl, or together form a benzene ring with the azine 'group to which they are attached, except for compounds in which the heterocycle containing the substituents A 1 , A 2 , A 3 and
  • the substituents A 1 , A 2 , A 3 , and A 4 and R in the formula (Tf-b) have the following preferred meanings in particular: A 1 , A 2 , A 3 and A 4 are identical or different and each preferably represents N (nitrogen) or the grouping CR, but the heterocycle containing the substituents A 1 , A 2 , A 3 and A 4 in each case contains 2 or 3 N atoms and in no case is more than two N atoms adjacent, and where R in the groupings CR can in each case have the same or different meanings in accordance with the definition below.
  • R in each case preferably represents H (hydrogen), nitro, amino, cyano, halogen, or alkyl, alkoxy, alkylthio, alkylsulfinyl, alkylsulfonyl, alkylamino or dialkylamino, each of which is optionally substituted by cyano, halogen or C 1 -C 4 -alkoxy 6 carbon atoms in the alkyl groups, or optionally two adjacent R groups together represent alkanediyl having 3 to 5 carbon atoms or together with the azine group to which they are attached form a benzene ring.
  • a 1 , A 2 , A 3 and A 4 are the same or different and each particularly preferably represents N (nitrogen) or the group CR, but the heterocycle containing the substituents A 1 , A 2 , A 3 and A 4 in each Case contains 2 or 3 N atoms and in no case are more than two N atoms adjacent and where R in the CR groups in the individual cases can have the same or different meanings according to the definition below.
  • R in each case particularly preferably represents H (hydrogen), nitro, amino, cyano, fluorine, chlorine, bromine, iodine, or in each case optionally by cyano, fluorine, chlorine, bromine, methoxy, ethoxy, n- or i-propoxy, n -, i-, s- or t-butoxy substituted methyl, ethyl, n- or i-propyl, n-, i-, s- or t-butyl, methoxy, ethoxy, n- or i-propoxy, n-, i-, s- or t-butoxy, methylthio, ethylthio, n- or i-propylthio, n-, i-, s- or t-butylthio, methylsulfinyl, ethylsulfinyl, n- or i-propylsulfin
  • Ethylamino, n- or i-propylamino, n-, i-, s- or t-butylamino, dimethylamino or diethylamino, or optionally two adjacent R groups together represent propane-1,3-diyl, butane-1,3- diyl, butane-1,4-diyl, pentane-1, 3-diyl, pentane-1,4-diyl or pentane-1,5-diyl or together with the azine group to which they are attached form a benzene ring ,
  • a 1 , A 2 , A 3 and A 4 are the same or different and each very particularly preferably represents N (nitrogen) or the grouping CR, but the heterocycle 2 containing the substituents A 1 , A 2 , A 3 and A 4 Contains N atoms and where R in the groupings CR can in each case have the same or different meanings in accordance with the definition below.
  • R each very particularly preferably represents H (hydrogen), nitro, amino, cyano, fluorine, chlorine, bromine, iodine, or in each case optionally by cyano, fluorine, chlorine, bromine, methoxy, ethoxy, n- or i-propoxy, n-, i-, s- or t-butoxy substituted methyl, ethyl, n- or i-propyl, n-, i-, s- or t-butyl, methoxy, ethoxy, n- or i-propoxy, n- , i-, s- or t-butoxy, methylthio, ethylthio, n- or i-propylthio, n-, i-, s- or t-butylthio, methylsulfinyl, ethylsulfinyl, n- or i-propylsulfiny
  • radicals R are identical or different and have one of the meanings given above.
  • radical definitions listed above apply both to the end products of the formula (I) and correspondingly to the starting or intermediate products of the formula (If) required in each case for the preparation. These radical definitions can be combined with one another, that is to say also between the specified preferred ranges.
  • hydrocarbon radicals such as alkyl - in each case straight-chain or branched - as far as possible - also in conjunction with heteroatoms such as in alkoxy.
  • the compounds of the formula (I) or (H) or (u-b) can, if appropriate, also be used as stereoisomers, i.e. exist as geometric and / or as optical isomers or isomer mixtures in different compositions. Both the pure stereoisomers and any mixtures of these isomers are the subject of this invention, even if only the compounds of the formula (I) or (U) or (U-b) are mentioned here in general.
  • the compounds of the formula (I) or (IT) or (Ub) have acidic or basic properties and can form salts. If the compounds of the formula (I) carry hydroxyl, carboxy or other groups which induce acidic properties, these compounds can be reacted with bases to form salts.
  • bases are, for example, hydroxides, carbonates, hydrogen carbonates of the alkali and alkaline earth metals, in particular those of sodium, potassium, magnesium and calcium, furthermore ammonia, primary, Secondary and tertiary amines with (Ci -C4) alkyl radicals and mono-, di- and trialkanolamines of (C ⁇ -C4) alkanols.
  • acids are, for example, mineral acids, such as salt, sulfuric and phosphoric acid, organic acids, such as acetic acid or oxalic acid, and acid salts, such as NaHSO4 and KHSO4.
  • the salts obtainable in this way also have fungicidal, insecticidal, acaricidal and miticidal properties.
  • the invention also relates to the salt-like derivatives formed from compounds of the formula (I) or (II) or (U-b) by reaction with basic or acidic compounds, and to the N-oxides which can be prepared by customary oxygenation methods.
  • the new azinyl-imidazoazines of the general formula (I) or (JJ) or (u-b) have interesting biological properties. They are characterized in particular by strong arthropodicides (insecticidal and acaricidal) and nematicidal activity and can be used in agriculture, in the forest, in the protection of stocks and materials, and in the hygiene sector.
  • azinylalkyl azine carboxamides of the general formula (JJ) are obtained if azine carboxylic acid halides of the general formula (TU)
  • X 1 represents halogen
  • a 1 , A 2 , A 3 , A 4 and X have the meaning given above,
  • a diluent e.g. Methylene chloride
  • a reaction auxiliary such as e.g. Triethylamine, implemented at temperatures between 0 ° C and 150 ° C.
  • azine carboxylic acid halides of the general formula (HI) are known and / or can be prepared by processes known per se (cf. JP-03081263 - cited in Chem. Abstracts 115: 183112; JP-07010841 - cited in Chem. Abstracts 123: 32961; JP-07025853 - cited in Chem. Abstracts 123: 55702; WO-2000/015615; WO-2001/064674; WO-2003/044013).
  • EP-A 185 256 See also EP-A 185 256, EP-A 580 374, WO 00/35912, WO 01/09104, WO 01/70692, EP-A 185 256, EP-A 580 374, WO 00/35912, WO 01/09104 , WO 01/70692.
  • azinylalkylamines of the general formula (TV) are also known and / or can be prepared by processes known per se (cf. J. Heterocycl. Chem. 17 (1980), 1061-1064; J. Med. Chem. 46 (2003) , 461-473; J. Org. Chem.
  • Pyrimidine alkylamines can be prepared, for example, by hydrogenating cyaniopyrimidines with hydrogen in the presence of a palladium catalyst and in the presence of methanol as a diluent, or as indicated in JP 2004/083495.
  • cyanopyrimidines and also cyanopyrazines, and ways of preparing them are known, for example, from: JP 2000119258, 2000, Synth. Commun. 2000, 30, 1509; EP-A 841326, 1998, J. Chem. Soc. (C) 1967, 568; Synth. Commun. 2002, 32, 153; Pharm. Bull. 1955, 175; Heterocycles 1992, 33, 211; EP 462452 1991; Liebigs Ann. 1981, 333; Monatsh. Chem. 1956, 87, 526; Chem. Pharm. Bull. 1987, 35, 3119; Pest. Man.
  • condensation aid a condensation aid.
  • Water-extracting chemicals are particularly suitable as condensation aids. These preferably include acid anhydrides and acid halides, such as acetic anhydride, propionic anhydride, phosphorus (V) oxide (phosphorus pentoxide), phosphoryl chloride (phosphorus oxychloride), thionyl chloride, phosgene and diphosgene, in particular phosphoryl chloride.
  • the process according to the invention for preparing the compounds of the general formula (11) is advantageously carried out in the presence of a reaction auxiliary.
  • a reaction auxiliary As such all common inorganic or organic bases are suitable. These include, for example, alkaline earth metal or alkali metal hydrides, hydroxides, amides, alcoholates, acetates, carbonates or hydrogen carbonates, such as sodium hydride, sodium amide, sodium methylate, sodium ethylate, potassium tert-butoxide, sodium hydroxide, potassium hydroxide, Ammonium hydroxide, sodium acetate, potassium acetate, calcium acetate, ammonium acetate, sodium carbonate, potassium carbonate, potassium hydrogen carbonate, sodium hydrogen carbonate or ammonium carbonate and also tertiary amines, such as trimethylamine, triethylamine, tributylamine, N, N-dimethylaniline, pyridine, N-methylpiperidine, N, N-dimethylaminopyr Diaz
  • diluents are particularly suitable as diluents.
  • diluents include in particular aliphatic, alicyclic or aromatic, optionally halogenated hydrocarbons, such as, for example, gasoline, benzene, toluene, xylene, chlorobenzene, dichlorobenzene, petroleum ether, hexane, cyclohexane, dichloromethane, chloroform and carbon tetrachloride.
  • reaction temperatures can be varied within a substantial range when carrying out the process according to the invention for the preparation of the compounds of the general formulas (I) and (JJ). In general, temperatures between 0 ° C and 150 ° C, preferably between 10 ° C and 120 ° C.
  • the process according to the invention is generally carried out under normal pressure. However, it is also possible to carry out the process according to the invention under elevated or reduced pressure - generally between 0.1 bar and 10 bar.
  • the starting materials are generally used in approximately equimolar amounts. However, it is also possible to use one of the components in a larger excess.
  • the reaction is generally carried out in a suitable diluent in the presence of a reaction auxiliary and the reaction mixture is generally stirred at the required temperature for several hours. Working up is carried out according to customary methods (cf. the production examples).
  • the starting materials of the formula (JJ) are prepared from the compounds of the formulas (JJJ) and (TV) by a known method using a reaction auxiliary and a diluent. After the reaction mixture has been largely concentrated, the remaining amount is shaken with water and an organic solvent which is practically immiscible with water. After the aqueous phase has been adjusted to an approximately neutral value, the organic phase is separated off and, after drying, the solvent is removed under reduced pressure. The so obtained Compounds of formula (U) are then condensed to the compounds of formula (I) without further purification.
  • corresponding compounds of the formula (I) in which X is halogen are obtained from the compounds of the formula (I) in which X is H (hydrogen), in which X is halogen by reaction with suitable halogenating agents, e.g. Chlorine, bromine, iodine, N-chlorosuccinimide, N-bromosuccinimide or N-iodosuccinimide in the presence of suitable diluents, such as e.g. Tetrachloromethane and / or acetonitrile, at temperatures between -20 ° C and + 50 ° C (cf. the preparation examples).
  • suitable halogenating agents e.g. Chlorine, bromine, iodine, N-chlorosuccinimide, N-bromosuccinimide or N-iodosuccinimide in the presence of suitable diluents, such as e.g. Tetrachloromethane and / or acet
  • corresponding compounds of the formula (I) in which X is formyl are obtained from the compounds of the formula (I) in which X is H (hydrogen) by reaction with with formylating agents, such as, for example, N, N-dimethylformamide , in the presence of phosphoryl chloride (POCl 3 ) at temperatures between -20 ° C and + 100 ° C and subsequent work-up in the presence of aqueous ammonia (cf. the preparation examples).
  • formylating agents such as, for example, N, N-dimethylformamide
  • POCl 3 phosphoryl chloride
  • Corresponding oximes or oxime ethers can be obtained from the formyl compounds of the formula (I) thus obtained by reaction with hydroxylamine or O-substituted hydroxylamines (cf. the preparation examples).
  • corresponding compounds of the formula (I) in which X is optionally substituted aryl are obtained from the compounds of the formula (I) in which X is halogen by reaction with corresponding arylboronic acids in the presence of reaction auxiliaries, such as, for example, tetrakis (triphenylphosphine) ) -palladium (PdrP (C 6 H 5 ) 3 ]) and sodium carbonate, in the presence of a diluent, such as toluene, and under an inert gas atmosphere (e.g. argon), at temperatures between 0 ° C and 150 ° C (" Suzuki cross clutch ", see the manufacturing examples).
  • reaction auxiliaries such as, for example, tetrakis (triphenylphosphine) ) -palladium (PdrP (C 6 H 5 ) 3 ]
  • a diluent such as toluene
  • an inert gas atmosphere e.g. argon
  • corresponding derivatives of the formula (I) in which X is optionally substituted arylethynyl are obtained by reaction with corresponding optionally substituted arylacetylenes in the presence of reaction auxiliaries, such as bis- triphenylphosphine) palladium dichloride ([(PC 6 H 5 ) 3 ] 2 PdCl 2 ), copper (I) iodide (Cul) and triethylamine, in the presence of a diluent such as tetrahydrofuran and under an inert gas atmosphere (e.g. Argon), at temperatures between 0 ° C and 50 ° C ("Sonogashira cross coupling", see the manufacturing examples).
  • reaction auxiliaries such as bis- triphenylphosphine) palladium dichloride ([(PC 6 H 5 ) 3 ] 2 PdCl 2 ), copper (I) iodide (Cul) and triethylamine, in the presence of a d
  • Both the compounds of the formula (I) and those of the formula (JJ), in particular those of the formula (JJ-b), are active ingredients.
  • the active substances are suitable for protecting plants and plant organs, for increasing crop yields, improving the quality of the crop and for controlling animal pests, in particular arthropods, such as insects and arachnids, and nematodes which in agriculture, in forests, in gardens and leisure facilities, in the protection of stored goods and materials, and in the hygiene sector.
  • animal pests in particular arthropods, such as insects and arachnids, and nematodes which in agriculture, in forests, in gardens and leisure facilities, in the protection of stored goods and materials, and in the hygiene sector.
  • arthropods such as insects and arachnids, and nematodes which in agriculture, in forests, in gardens and leisure facilities, in the protection of stored goods and materials, and in the hygiene sector.
  • They can preferably be used as pesticides. They
  • Isopoda e.g. Oniscus asellus, Armadillidium vulgare, Porcellio scaber.
  • Thysanura e.g. Lepisma saccharina.
  • Orthoptera e.g. Acheta domesticus, Gryllotalpa spp., Locusta migratoria migratorioides, Melanoplus spp., Schistocerca gregaria.
  • Phthiraptera e.g. Pediculus humanus corporis, Haematopinus spp., Linognathus spp., Trichodectes spp., Damalinia spp ..
  • Thysanoptera e.g. Hercinothrips femoralis, Thrips tabaci, Thrips palmi, Frankliniella accidentalis.
  • Otiorrhynchus sulcatus Otiorrhynchus sulcatus, Cosmopolites sordidus, Ceuthorrhynchus assimilis, Hypera postica, Dermestes spp., Trogoderma spp., Anthrenus spp., Attagenus spp., Lyctus spp., Meligethes aeneus, Ptinus spp., Giptusibbium psol. Tenebrio molitor, Agriotes spp., Conoderus spp., Melolontha melolontha, Amphimallon solstitialis, Costelytra zealandica, Lissorhoptrus oryzophilus.
  • Hymenoptera e.g. Diprion spp., Hoplocampa spp., Lasius spp., Monomorium pharaonis, Vespa spp.
  • Scorpio maurus Latrodectus mactans, Acarus siro, Argas spp., Ornithodoros spp., Dermanyssus gallinae, Eriophyes ribis, Phyllocoptruta oleivora, Boophilus spp., Rhip ⁇ cephalus spp., Amblyommomma spp., ., Psoroptes spp., Chorioptes spp., Sarcoptes spp., Tarsonemus spp., Bryobia praetiosa, Panonychus spp., Tetranychus spp., Hemitarsonemus spp., Brevipalpus spp ..
  • Plant parasitic nematodes include, for example, Pratylenchus spp., Radopholus similis, Ditylenchus dipsaci, Tylenchulus semipenetrans, Heterodera spp., Globodera spp., Meloidogyne spp., Aphelenchoides spp., Longidorus spp., Tripusichpp. Spp., Xiphinema spp. ,
  • the compounds according to the invention are preferably suitable for controlling sucking insects, such as aphids (for example Aphis fabae, Aphis pomi, Aphis spiraecola, Aphis gossypii, Aphis nasturtii, Dysaphis plantaginea, Eriosoma spp., Rhopalosiphum padi, Acyrthosiphon pisumica, Pemphigususus, Pemphigusus, Pemphigusus, Pemphigusus, Pemphigususus, Pemphigususus, Pemphigususus, Pemphigususus, Pemphigususus, Pemphigususus, Pemphigususus, Pemphigusus, Pemphigusus, Pemphigusus, Pemphigusus, pemphigusus, pemphigusus, pemphigusus, pemphigus
  • the active compounds according to the invention act not only against pests from plants, hygiene and stored products, but also in the veterinary sector against animal parasites (ectoparasites) such as tick ticks, leather ticks, mites, running mites, flies (stinging and licking), parasitic fly larvae, lice, hair lice, Featherlings and fleas.
  • animal parasites ectoparasites
  • tick ticks leather ticks
  • mites running mites
  • flies stinging and licking
  • parasitic fly larvae lice, hair lice, Featherlings and fleas.
  • Anoplurida e.g. Hae atopinus spp., Linognathus spp., Pediculus spp., Phtirus spp., Solenopotes spp.
  • Nematocerina and Brachycerina e.g. Aedes spp., Anopheles spp., Culex spp., Simulium spp., Eusimulium spp., Phlebotomus spp., Lutzomyia spp., Culicoides spp., Chrysops spp., Hybomitra spp., Atylotus spp., Tabanus spp., Haematopota ., Philipomyia spp., Braula spp., Musca spp., Hydrotaea spp., Stomoxys spp., Haematobia spp., Morellia spp., Fannia spp., Glossina spp., Calliphora spp., Glossina spp., Calliphora spp., Glossina spp.,
  • Siphonaptrida e.g. Pulex spp., Ctenocephalides spp., Xenopsylla spp., Ceratophyllus spp.
  • Actinedida Prostigmata
  • Acaridida Acaridida
  • Acarapis spp. Cheyletiella spp., Ornitrocheyletia spp., Myobia spp., Psorergates spp., Demodex spp., Trombicula spp., Listrophorus spp., Acarus spp., Tyrophagus spp., Caloglyphus spp., Hypodterol spp ., Psoroptes spp., Chorioptes spp., Otodectes spp., Sarcoptes spp., Notoedres spp., Knemidocoptes spp., Cytodites spp., Laminosioptes spp.
  • Protozoa such as Eimeria can also be controlled.
  • the active compounds of the formula (I) or (JJ) or (U-b) according to the invention are also suitable for combating arthropods which are used in agricultural animals, e.g. Cattle, sheep, goats, horses, pigs, donkeys, camels, buffalo, rabbits, chickens, turkeys, ducks, geese, bees, other pets such as e.g. Dogs, cats, house birds, aquarium fish and so-called experimental animals such as Infest hamsters, guinea pigs, rats and mice.
  • arthropods e.g. Cattle, sheep, goats, horses, pigs, donkeys, camels, buffalo, rabbits, chickens, turkeys, ducks, geese, bees, other pets such as e.g. Dogs, cats, house birds, aquarium fish and so-called experimental animals such as Infest hamsters, guinea pigs, rats and mice.
  • the active compounds according to the invention are used in the veterinary sector in a known manner by enteral administration in the form of, for example, tablets, capsules, drinkers, Drenches, granules, pastes, boluses, the feed-through method, from suppositories, by parenteral administration, such as by injections (intramuscular, subcutaneous, intravenous, intraperitoneal, etc.), implants, by nasal application, by dermal application in the form, for example of diving or bathing (dipping), spraying (spray), pouring on (pour-on and spoton), washing, powdering and with the help of shaped articles containing active ingredients, such as necklaces, ear tags, tail tags, limb tapes, holders, marking devices, etc.
  • enteral administration in the form of, for example, tablets, capsules, drinkers, Drenches, granules, pastes, boluses, the feed-through method, from suppositories
  • parenteral administration such as by injections (intramuscular
  • the active compounds of the formula (I) or (U) or (Ub) can be used as formulations (for example powders, emulsions, flowable agents) which contain the active compounds in general in an amount of Contain 1 to 80% by weight, apply directly or after 100 to 10,000-fold dilution or use them as a chemical bath.
  • the compounds according to the invention show a high insecticidal activity against insects which destroy industrial materials.
  • insects may be mentioned by way of example and preferably, but without limitation:
  • Hymenoptera such as Sirex juvencus, Urocerus gigas, Urocerus gigas taignus, Urocerus augur;
  • Termites such as Kalotermes flavicollis, Cryptotermes brevis, Heterotermes indicola, Reticulitermes flavipes, Reticulitermes santonensis, Reticulitermes lucifugus, Mastotermes darwiniensis, Zootermopsis nevadensis, Coptotermes formosanus; Bristle tails, such as Lepisma saccharina.
  • non-living materials such as preferably plastics, adhesives, glues, papers and cartons, leather, wood, wood processing products and paints.
  • the material to be protected against insect attack is very particularly preferably Wood and wood processing products.
  • Wood and wood processing products that can be protected by the agent according to the invention or mixtures containing it are to be understood as examples:
  • the active ingredients can be used as such, in the form of concentrates or in a conventional manner
  • Formulations such as powders, granules, solutions, suspensions, emulsions or pastes can be used.
  • the formulations mentioned can be prepared in a manner known per se, e.g. by mixing the active ingredients with at least one solvent or diluent, emulsifier, dispersant and / or binder or fixative, water repellent, optionally siccatives and UV stabilizers and optionally dyes and pigments and further processing aids.
  • the insecticidal compositions or concentrates used to protect wood and wood-based materials generally contain the active compound according to the invention in a concentration of 0.0001 to 95% by weight, in particular 0.001 to 60% by weight.
  • the amount of the agents or concentrates used depends on the type and occurrence of the insects and on the medium. The optimum amount of use can be determined in each case by test series. In general, however, it is sufficient to use 0.0001 to 20% by weight, preferably 0.001 to 10% by weight, of the active compound, based on the material to be protected.
  • Protozones such as Eimeroa can also be combated.
  • the substances according to the invention have a strong microbicidal action and can be used to control unwanted microorganisms, such as fungi and bacteria, in crop protection and in material protection.
  • Fungicides can be used to protect plants against Plasmodiophoromycetes, Oomycetes, Chytridiomycetes, Zygomycetes, Ascomycetes, Basidiomycetes and Deuteromycetes.
  • Bactericides can be used in crop protection to combat Pseudomonadaceae, Rhizobiaceae, Enterobacteriaceae, Corynebacteriaceae and Streptomycetaceae.
  • Xanthomonas species such as, for example, Xanthomonas campestris pv. Oryzae;
  • Pseudomonas species such as, for example, Pseudomonas syringae pv. Lachrymans;
  • Erwinia species such as, for example, Erwinia amylovora;
  • Pythium species such as, for example, Pythium ultimum
  • Phytophthora species such as, for example, Phytophthora infestans
  • Pseudoperonospora species such as, for example, Pseudoperonospora humuli or
  • Plasmopara species such as, for example, Plasmopara viticola
  • Bremia species such as, for example, Bremia lactucae
  • Peronospora species such as, for example, Peronospora pisi or P. brassicae;
  • Erysiphe species such as, for example, Erysiphe graminis
  • Sphaerotheca species such as, for example, Sphaerotheca fuliginea
  • Podosphaera species such as, for example, Podosphaera leucotricha
  • Venturia species such as, for example, Venturia inaequalis
  • Pyrenophora species such as, for example, Pyrenophora teres or P. graminea
  • Cochliobolus species such as, for example, Cochliobolus sativus
  • Drechslera (Conidial form: Drechslera, Syn: Helminthosporium);
  • Uromyces species such as, for example, Uromyces appendiculatus
  • Puccinia species such as, for example, Puccinia recondita
  • Sclerotinia species such as, for example, Sclerotinia sclerotiorum
  • Tilletia species such as, for example, Tilletia caries
  • Ustilago species such as, for example, Ustilago nuda or Ustilago avenae;
  • Pellicularia species such as, for example, Pellicularia sasakii;
  • Pyricularia species such as, for example, Pyricularia oryzae
  • Fusarium species such as, for example, Fusarium culmorum
  • Botrytis species such as, for example, Botrytis cinerea
  • Septoria species such as, for example, Septoria nodorum
  • Leptosphaeria species such as, for example, Leptosphaeria nodorum;
  • Cercospora species such as, for example, Cercospora canescens
  • Alternaria species such as, for example, Alternaria brassicae;
  • Pseudocercosporella species such as, for example, Pseudocercosporella herpotrichoides.
  • the active compounds according to the invention also have a strong strengthening effect in plants. They are therefore suitable for mobilizing the plant's own defenses against attack by unwanted microorganisms.
  • Plant-strengthening (resistance-inducing) substances are to be understood in the present context as those substances which are able to stimulate the defense system of plants in such a way that the treated plants develop extensive resistance to these microorganisms when subsequently inoculated with undesirable microorganisms.
  • Undesired microorganisms are to be understood in the present case as phytopathogenic fungi, bacteria and viruses.
  • the substances according to the invention can therefore be used to treat plants within a certain period of time after the treatment against attack by the abovementioned Protect pathogens.
  • the period of time within which protection is brought about generally extends from 1 to 10 days, preferably 1 to 7 days, after the plants have been treated with the active compounds.
  • the active compounds according to the invention can be used with particularly good results in combating cereal diseases, such as Ustilago avenae.
  • the active compounds according to the invention are also suitable for increasing the crop yield. They are also less toxic and have good plant tolerance.
  • the active compounds according to the invention can also be used in certain concentrations and application rates as herbicides and for influencing plant growth. If appropriate, they can also be used as intermediates and precursors for the synthesis of further active compounds.
  • Plants are understood here to mean all plants and plant populations, such as desired and undesired wild plants or crop plants (including naturally occurring crop plants).
  • Crop plants can be plants which can be obtained by conventional breeding and optimization methods or by biotechnological and genetic engineering methods or combinations of these methods, including the transgenic plants and including the plant cultivars which can or cannot be protected by plant breeders' rights.
  • Plant parts are to be understood to mean all above-ground and underground parts and organs of the plants, such as shoots, leaves, flowers and roots, examples being leaves, needles, stems, stems, flowers, fruiting bodies, fruits and seeds as well as roots, tubers and rhizomes.
  • the plant parts also include crops and vegetative and generative propagation material, for example cuttings, tubers, rhizomes, offshoots and seeds.
  • the treatment of the plants and parts of plants with the active compounds according to the invention is carried out directly or by acting on their surroundings, living space or storage space in accordance with the customary treatment methods, for example by dipping, spraying, evaporating, atomizing, scattering, spreading, injecting and in the case of propagation material, in particular seeds. continue by wrapping one or more layers.
  • the substances according to the invention can be used to protect technical materials against attack and destruction by undesired microorganisms.
  • technical materials are understood to mean non-living materials that have been prepared for use in technology.
  • technical materials which are to be protected against microbial change or destruction by active substances according to the invention can be adhesives, glues, paper and cardboard, textiles, leather, wood, paints and plastic articles, cooling lubricants and other materials which can be attacked or decomposed by microorganisms .
  • parts of production systems for example cooling water circuits, are also mentioned which can be impaired by the multiplication of microorganisms.
  • technical materials are preferably adhesives, glues, papers and cartons, leather, wood, paints, cooling lubricants and heat transfer liquids, particularly preferably wood.
  • Bacteria, fungi, yeasts, algae and mucilaginous organisms may be mentioned as microorganisms which can cause degradation or a change in the technical materials.
  • the active compounds according to the invention preferably act against fungi, in particular mold, wood-discoloring and wood-destroying fungi (Basidiomycetes) and against slime organisms and algae.
  • microorganisms of the following genera may be mentioned: Alternaria, such as Alternaria tenuis,
  • Aspergillus such as Aspergillus niger
  • Chaetomium like Chaetomium globosum
  • Coniophora such as Coniophora puetana
  • Lentinus such as Lentinus tigrinus
  • Penicillium such as Penicillium glaucum
  • Polyporus such as Polyporus versicolor
  • Aureobasidium such as Aureobasidium pullulans
  • Sclerophoma such as Sclerophoma pityophila
  • Trichoderma such as Trichoderma viride
  • Escherichia such as Escherichia coli
  • Pseudomonas such as Pseudomonas aeruginosa
  • Staphylococcus such as Staphylococcus aureus.
  • the active ingredients can be converted into the customary formulations, such as solutions, emulsions, suspensions, powders, foams, pastes, granules, aerosols, very fine encapsulations in polymeric substances and in coating compositions for seeds, and ULV -Cold and warm mist formulations.
  • formulations are made in a known manner, e.g. by mixing the active ingredients with extenders, that is to say liquid solvents, pressurized liquefied gases and / or solid carriers, if appropriate using surface-active agents, that is to say emulsifiers and / or dispersants and / or foam-generating agents. If water is used as an extender, e.g. organic solvents can also be used as auxiliary solvents.
  • extenders that is to say liquid solvents, pressurized liquefied gases and / or solid carriers, if appropriate using surface-active agents, that is to say emulsifiers and / or dispersants and / or foam-generating agents.
  • surface-active agents that is to say emulsifiers and / or dispersants and / or foam-generating agents.
  • water e.g. organic solvents can also be used as auxiliary solvents.
  • aromatics such as xylene, toluene or alkylnaphthalenes
  • chlorinated aromatics or chlorinated aliphatic hydrocarbons such as chlorobenzenes, chlorethylenes or methylene chloride
  • aliphatic hydrocarbons such as cyclohexane or paraffins, e.g. Petroleum fractions, alcohols, such as butanol or glycol, and their ethers and esters, ketones, such as acetone, methyl ethyl ketone, methyl isobutyl ketone or cyclohexanone
  • strongly polar solvents such as dimethylformamide and dimethyl sulfoxide, and water.
  • Liquefied gaseous extenders or carriers mean liquids which are gaseous at normal temperature and pressure, e.g. Aerosol propellants, such as halogenated hydrocarbons as well as butane, propane, nitrogen and carbon dioxide.
  • Possible solid carriers are: e.g. natural rock meals, such as kaolins, clays, talc, chalk, quartz, attapulgite, montmorillonite or diatomaceous earth and synthetic rock meals, such as highly disperse silica, aluminum oxide and silicates. The following are suitable as solid carriers for granules: e.g.
  • emulsifiers and / or foaming agents are: e.g. nonionic and anionic emulsifiers such as polyoxyethylene fatty acid esters, polyoxyethylene fatty alcohol ethers, e.g. Alkylaryl polyglycol ether, alkyl sulfonates, alkyl sulfates, aryl sulfonates and protein hydrolyzates.
  • Possible dispersants are: e.g. Lignin sulfite liquor and methyl cellulose.
  • Adhesives such as carboxymethyl cellulose, natural and synthetic polymers in the form of powders, granules or latices, such as gum arabic, polyvinyl alcohol, polyvinyl acetate, and also natural phospholipids, such as cephalins and lecithins, and synthetic phospholipids can be used in the formulations.
  • Other additives can be mineral and vegetable oils.
  • Dyes such as inorganic pigments, for example iron oxide, titanium oxide, ferrocyan blue, and organic dyes, such as alizarin, azo and metal phmalocyanine dyes, and trace nutrients, such as salts of iron, manganese, boron, copper, cobalt, molybdenum and zinc, can be used .
  • the formulations generally contain between 0.1 and 95 percent by weight of active compound, preferably between 0.5 and 90%.
  • the active compounds according to the invention can also be used in a mixture with known fungicides, bactericides, acaricides, nematicides or insecticides, in order, for example, to to broaden the spectrum of activity or to prevent the development of resistance.
  • fungicides bactericides
  • acaricides nematicides or insecticides
  • synergistic effects are obtained, i.e. the effectiveness of the mixture is greater than the effectiveness of the individual components.
  • Ampropylfos Ampropylfos-potassium; andoprim; anilazine; azaconazole; azoxystrobin;
  • Buthiobate butylamine; Calcium polysulfide; capsimycin; captafol; captan; carbendazim; carboxin; carpropamid; carvones; chinomethionat; Chlobenthiazone; Chlorfenazole; chloroneb;
  • chlorothalonil chlozolinate; Clozylacon; cyazofamid; cyflufenamid; cymoxanil; Cyproconazole; cyprodinil; cyprofuram; Dagger G; debacarb; dichlofluanid; dichlone; dichlorophen;
  • dimethomorph dimoxystrobin; diniconazole; Diniconazole-M; dinocap; diphenylamines; Dipyrithione; Ditalimfos; dithianon; dodine; Drazoxolon; edifenphos; epoxiconazole;
  • Fenbuconazole fenfuram; fenhexamid; Fenitropan; fenoxanil; fenpiclonil; fenpropidin;
  • fenpropimorph ferbam; fluazinam; Flubenzimine; fludioxonil; flumetover; flumorph;
  • fluoromides fluoxastrobin; fluquinconazole; flurprimidol; flusilazole; flusulfamide; flutolanil; flutriafol; folpet; Fosetyl-Al; Fosetyl-sodium; fuberidazole; furalaxyl; furametpyr; Furcarbanil;
  • iprodione iprovalicarb; Jjumamycin; isoprothiolane; Isovaledione; kasugamycin; Kresoxim-methyl; mancozeb; maneb; Meferimzone; mepanipyrim; mepronil; metalaxyl; Metalaxyl-M; metconazole; methasulfocarb; Methfuroxam; metiram; metominostrobin; Metsulfovax;
  • phthalides phthalides; picoxystrobin; piperalin; Polyoxins; Polyoxorim; Probenazole; prochloraz; Procymidones; propamocarb; Propanosine-sodium; propiconazole; propineb; proquinazid; Prothio- conazoles; pyraclostrobin; Pyrazohos; pyrifenox; pyrimethanil; pyroquilon; Pyroxyfur; Pyrrolnitrine; Quinconazole; quinoxyfen; quintozene; Simeconazole; spiroxamine; Sulfur; tebuconazole; tecloftalam; Tecnazene; Tetcyclacis; tetraconazole; thiabendazole; Thicyofen; Thifluzamide; Thiophanate-methyl; thiram; Tioxymid; Tolclofos-methyl; tolylfluanid; triadimefon; triadi
  • copper salts and preparations such as Bordeaux mixture; Copper hydroxide; Copper naphthenate; Copper oxychloride; Copper sulfate; Cufraneb; Cuprous oxide; mancopper; Oxine-copper.
  • DDT Deltamethrin, Demeton-S-methyl, Demeton-S-methylsulphone, Diafenthiuron, Dialifos, Diazinone, Dichlofenthion, Dichlorvos, Dicofol, Dicrotophos, Dicyclanil, Diflubenzuron, Dime- fluthrin, Dimetho Dinot, Dinobutonate, Dinobutonate, Dimobutinate, Dinobutinate, Dimobutinate, Dimobutinate Diofenolan, Disulfoton, Docusat-sodium, Dofenapyn, DOWCO-439,
  • Famphur Fenamiphos, fenazaquin, fenbutatin oxide, fenfluthrin, fenitrothion, fenobucarb, fenothiocarb, Fenoxacrim, fenoxycarb, fenpropathrin, fenpyrad, Fenpyrithrin, Fenpyroxhnate, fensulfothion, fenthion, Fentrifanil, fenvalerate, fipronil, flonicamid, fluacrypyrim, fluazuron, Flubenzimine, Flubrocythrinate, flucycloxuron , Flucythrinate, Flufenerim, Flufenoxuron, Flufen- prox, Flumethrin, Flupyrazofos, Flutenzin (Flufenzine), Fluvalinate, Fonofos, Formetanate, Formothion, Fosmethilan, Fosthi
  • Gamma-cyhalothrin gamma-HCH, gossyplure, grandlure, granulovirus
  • Halofenozide HCH, HCN-801, Heptenophos, Hexaflumuron, Hexythiazox, Hydra-methylnone, Hydroprene,
  • Kadethrin nuclear polyhedron viruses, kinoprene, Lambda-cyhalothrin, lindane, lufenuron,
  • Mecarbam Malathion, Mecarbam, Mesulfenfos, Metaldehyde, Metam-sodium, Methacrifos, Methamidophos, Metharhician anisopliae, Metharhician flavoviride, Methidathione, Methiocarb, Methomyl, Methoprene, Methoxychlor, Methoxyfenozide, Metofluthrin, Metolcarb, Meteveminphine Zone, MetoxcarbinMoxinphinzone MK 245, MON-45700, Monocrotophos, Moxidectin, MTI-800,
  • NC-104 NC-170, NC-184, NC-194, NC-196, Niclosamide, Nicotine, Nitenpyram, Nithiazine, NNI-0001, NNI-0101, NNI-0250, NNI-9768, Novaluron, Noviflumuron,
  • Paecilomyces fumosoroseus Parathion-methyl, Parathion (-ethyl), Peninhrin (eis, trans-), Petroleum, PH-6045, Phenothrin (IR-trans isomer), Phenthoate, Phorate, Phosalone, Phosmet, Phosphamidon, Phosphocarb, Phoxim, Piperonyl butoxide, Pirimicarb, Pirimiphos-methyl, Pirimiphos-ethyl, Potassium oleate, Prallethrin, Profenofos, Profluthrin, Promecarb, Propaphos, Propargite, Propetamphos, Propoxur, Prothiofos, Prothoate, Protrifenbute, Pyymmetclhrin, Pyrometrozhrin, Pyrometrozhrin Pyridaben, pyridalyl, pyridaphenthion, pyridathione, pyr
  • a mixture with other known active compounds, such as herbicides, or with fertilizers and growth regulators, safeners or semicochemicals is also possible.
  • the compounds of the formula (T) or (JJ) or (U-b) according to the invention also have very good antifungal effects. They have a very broad spectrum of antifungal effects, especially against dermatophytes and shoot fungi, mold and diphasic fungi (e.g. against Candida species such as Candida albicans, Candida glabrata) as well as Epidermophyton floccosum, Aspergillus species such as Aspergillus niger and Aspergillichusophytonyumumatus fumigatus Trichophyton mentagrophytes, Microsporon species like Microsporon canis and audouinii.
  • the list of these mushrooms in no way represents a limitation of the detectable mycotic spectrum, but is only of an explanatory nature.
  • the active compounds can be used as such, in the form of their formulations or the use forms prepared therefrom, such as ready-to-use solutions, suspensions, wettable powders, pastes, soluble powders, dusts and granules. They are used in the usual way, e.g. by watering, spraying, atomizing, scattering, dusting, foaming, brushing, etc. It is also possible to apply the active ingredients using the ultra-low-volume process or to inject the active ingredient preparation or the active ingredient into the soil itself. The seeds of the plants can also be treated.
  • the application rates can be varied within a relatively wide range, depending on the type of application.
  • the active compound application rates are generally between 0.1 and 10,000 g / ha, preferably between 10 and 1,000 g / ha.
  • the active compound application rates are generally between 0.001 and 50 g per kilogram of seed, preferably between 0.01 and 10 g per kilogram of seed.
  • the active compound application rates are generally between 0.1 and 10,000 g / ha, preferably between 1 and 5,000 g / ha.
  • the active compounds according to the invention can furthermore be present in their customary formulations and in the use forms prepared from these formulations in a mixture with synergists.
  • Synergists are compounds that increase the effectiveness of the active ingredients without the added synergist itself having to be active.
  • the active compounds according to the invention can also be present in their commercially available formulations and in the use forms prepared from these formulations in mixtures with inhibitors which reduce degradation of the active compound after use in the environment of the plant, on the surface of parts of plants or in plant tissues ,
  • the active substance content of the use forms prepared from the commercially available formulations can vary within wide ranges.
  • the active substance concentration of the use forms can be from 0.0000001 to 95% by weight of active substance, preferably between 0.0001 and 1% by weight.
  • the application takes place in a customary manner adapted to the application forms.
  • the active substance When used against hygiene pests and pests of stored products, the active substance is distinguished by an excellent residual action on wood and clay and by a good stability to alkali on limed substrates.
  • all plants and their parts can be treated.
  • wild plant species or plant species and their parts obtained by conventional biological breeding methods such as crossing or protoplast fusion
  • transgenic plants and plant cultivars which have been obtained by genetic engineering methods if appropriate in combination with conventional methods (genetic modified organisms) and their parts are treated.
  • the term "parts” or “parts of plants” or “plant parts” was explained above.
  • Plants of the plant varieties which are in each case commercially available or in use are particularly preferably treated according to the invention.
  • Plant cultivars are understood to mean plants with new properties (“traits”) which have been grown both by conventional breeding, by mutagenesis or by recombinant DNA techniques. These can be varieties, breeds, bio and genotypes. Depending on the plant species or plant cultivars, their location and growth conditions (soils, climate, growing season, nutrition), the treatment according to the invention can also cause superadditive (“synergistic”) effects.
  • the preferred transgenic (genetically engineered) plants or plant cultivars to be treated according to the invention include all plants which, through the genetic engineering modification, have received genetic material which gives these plants particularly advantageous, valuable properties (“traits”). Examples of such properties are better plant growth, increased tolerance to high or low temperatures, increased tolerance to drought or to water or soil salt content, increased flowering performance, easier harvesting, accelerated ripening, higher crop yields, higher quality and / or higher nutritional value of the harvested products, higher shelf life and / or workability of the harvested products.
  • Such properties are an increased defense of the plants against animal and microbial pests, such as against insects, mites, phytopathogenic fungi, bacteria and / or viruses, and an increased tolerance of the plants to certain herbicidal active ingredients.
  • the important crop plants such as cereals (wheat, rice), corn, soybeans, potatoes, cotton, tobacco, rapeseed and fruit plants (with the fruits apples, pears, citrus fruits and grapes) are mentioned as examples of transgenic plants, with corn, soybeans , Potato, cotton, tobacco and rapeseed are highlighted.
  • the traits that are particularly emphasized are the increased defense of the plants against insects, arachnids, nematodes and snails by toxins arising in the plants, in particular those which are caused by the genetic material from Bacillus thuringiensis (for example by the genes Cry ⁇ A (a) , CryIA (b), Cry ⁇ A (c), CryJJA, CrylJJA, CryHJB2, Cry9c Cry2Ab, Cry3Bb and CrylF as well as their combinations) are produced in the plants (hereinafter "Bt plants”).
  • the properties (“traits”) also particularly emphasize the increased defense of plants against fungi, bacteria and viruses by systemic acquired resistance (SAR), systemin, phytoalexins, elicitors and resistance genes and correspondingly expressed proteins and toxins.
  • the properties (“traits”) which are particularly emphasized are the increased tolerance of the plants to certain herbicidal active compounds, for example imidazolinones, sulfonylureas, glyphosate or phosphinotricin (for example “PAT” gene).
  • the genes conferring the desired properties (“traits”) can also occur in combinations with one another in the transgenic plants.
  • Bt plants are corn varieties, cotton varieties, soy varieties and potato varieties that are sold under the trade names YTELD GARD® (e.g. corn, cotton, soy), KnockOut® (e.g. corn), StarLink® (e.g. corn), Bollgard® ( Cotton), Nucotn® (cotton) and NewLeaf® (potato).
  • herbicide-tolerant plants are maize varieties, cotton varieties and soy varieties that are marketed under the trade names Roundup Ready® (tolerance to glyphosate e.g. corn, cotton, soy), Liberty Link® (tolerance to phosphinotricin, e.g.
  • rapeseed rapeseed
  • IMI® tolerance to Imidazolinone
  • STS® tolerance to sulfonylureas such as maize
  • the herbicide-resistant plants include the varieties sold under the name Clearfield® (eg maize). Of course, these statements also apply to plant varieties developed in the future or coming onto the market in the future with these or future-developed genetic properties ("traits").
  • plants listed can be treated particularly advantageously according to the invention with the compounds of the general formula (I) or (JJ) or (JJ-b) or the active compound mixtures according to the invention.
  • the preferred ranges given above for the active substances or mixtures also apply to the treatment of these plants. Plant treatment with the compounds or mixtures specifically listed in the present text should be particularly emphasized.
  • the compounds of the formula (I) or (U) or (U-b) or their salts are also notable for a pronounced repellent effect.
  • Repellent in the sense of the description is a substance or mixture of substances that has a protective or expelling effect on other living beings, in particular pests and nuisances.
  • the term also encompasses effects such as the antifeeding effect, in which the ingestion of food is disrupted or prevented (antagonistic effect), suppression of egg laying or influencing the development of the population.
  • the invention therefore also relates to the use of compounds of the formula (I) or (IT) or (U-b) or their salts to achieve the effects mentioned, in particular in the pests mentioned in the biological examples.
  • the invention also relates to a method for repelling or expelling harmful organisms, one or more compounds of the formula (I) or (JJ) or (JJ-b) or their salts being applied at the location from which the harmful organisms are kept away or to be distributed.
  • application can mean, for example, treatment of the plant or of the seed.
  • the compounds of the formula (I) or (JJ) or (üb) or their salts are distinguished in that - if one wishes to take advantage of the effects mentioned above - the agent is applied at an earlier point in time than is customary in the case of direct control. The effect often lasts for a long time, so that a duration of action of more than 2 months is achieved.
  • 4-CF 3 -pyridine-3-carboxylic acid (365 mg, 1.91 mmol) was dissolved in thionyl chloride (5 ml) and catalytic amounts of DMF were added. The reaction mixture was stirred at room temperature for 1.5 h and then under reflux for 1 h, then rotated in and used crude in the coupling step.
  • 4,6-Dimethoxy-2-aminomethylpyrimidine (355 mg, 2.1 mmol) was placed in triethylamine (0.35 ml, 2.48 mmol) and dichloromethane (10 ml) and slowly added dropwise at room temperature with a solution of the freshly prepared acid chloride (400 mg, 1.91 mmol) in dichloromethane (5 ml).
  • the compounds of formula (Tf) can be prepared as described above and in the literature cited above. Examples of the compounds of the formula (JJ) are listed in Table 2.
  • Solvent 7 parts by weight of dimethylformamide emulsifier: 2 parts by weight of alkylaryl polyglycol ether
  • Cotton leaves (Gossypium hirsutwn), which are heavily infested with the cotton aphid (Aphis gossypii), were treated by dipping into the preparation of active compound of the desired concentration.
  • the kill was determined in%. 100% means that all aphids have been killed; 0% means that no aphids have been killed.
  • Solvent 78 parts by weight of acetone, 1.5 parts by weight of dimethylformamide emulsifier: 0.5 part by weight of alkylaryl polyglycol ether
  • the effect was determined in%. 100% means that all aphids have been killed; 0% means that no aphids have been killed.
  • Nilaparvata lugens test hydroponic treatment
  • Solvent 78 parts by weight of acetone, 1.5 parts by weight of diniethylformamide
  • Emulsifier 0.5 part by weight of alkylaryl polyglycol ether
  • active compound 1 part by weight of active compound is mixed with the stated amounts of solvent and emulsifier and the concentrate is diluted to the desired concentration with water containing emulsifier.
  • the active ingredient preparation is pipetted into water.
  • the effect is determined in%. 100% means that all rice leafhoppers have been killed; 0% means that none of the leafhopper have been killed.
  • the compounds of Preparation Examples 3, 4, 16, 17, 23, 26, 54, 55, 100, 106 and 124 showed a degree of destruction of at least 70% after 7 days at a concentration of 100 g / ha.
  • Emulsifier 0.5 part by weight of alkylaryl polyglycol ether
  • active compound 1 part by weight of active compound is mixed with the stated amounts of solvent and emulsifier and the concentrate is diluted to the desired concentration with water containing emulsifier.
  • Chinese cabbage leaf slices (Brassica pekinensis), which are affected by all stages of the green peach aphid (Myzus persicae), are sprayed with an active ingredient preparation of the desired concentration.
  • the effect is determined in%. 100% means that all aphids have been killed; 0% means that no aphids have been killed.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Dentistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Environmental Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

L'invention concerne des imidazoazines d'azinyle de formule (I), dans laquelle les symboles ont la signification donnée dans la description, leurs sels et N-oxydes, leurs procédés de préparation et de nouveaux produits intermédiaires, ainsi que l'utilisation des composés de formule (I) et des produits intermédiaires pour combattre des infestations animales et des micro-organismes indésirables.
EP05737913A 2004-05-10 2005-04-29 Imidazoazines d'azinyle et carboxamides d'azinyle Withdrawn EP1751152A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004022897A DE102004022897A1 (de) 2004-05-10 2004-05-10 Azinyl-imidazoazine
PCT/EP2005/004616 WO2005113553A2 (fr) 2004-05-10 2005-04-29 Imidazoazines d'azinyle et carboxamides d'azinyle

Publications (1)

Publication Number Publication Date
EP1751152A2 true EP1751152A2 (fr) 2007-02-14

Family

ID=34966730

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05737913A Withdrawn EP1751152A2 (fr) 2004-05-10 2005-04-29 Imidazoazines d'azinyle et carboxamides d'azinyle

Country Status (13)

Country Link
US (1) US20080293674A1 (fr)
EP (1) EP1751152A2 (fr)
JP (1) JP2007536307A (fr)
KR (1) KR20070033980A (fr)
CN (1) CN1980926A (fr)
BR (1) BRPI0511025A (fr)
CA (1) CA2566074A1 (fr)
DE (1) DE102004022897A1 (fr)
EA (1) EA200602038A1 (fr)
MX (1) MXPA06013135A (fr)
TW (1) TW200607451A (fr)
WO (1) WO2005113553A2 (fr)
ZA (1) ZA200609252B (fr)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006068760A2 (fr) 2004-11-19 2006-06-29 The Regents Of The University Of California Pyrazolopyrimidines anti-inflammatoires
US7709468B2 (en) 2005-09-02 2010-05-04 Abbott Laboratories Imidazo based heterocycles
PT2004654E (pt) 2006-04-04 2013-08-27 Univ California Derivados de pirazolopirimidina para utilização como antagonistas da quinase
US7501438B2 (en) 2006-07-07 2009-03-10 Forest Laboratories Holdings Limited Pyridoimidazole derivatives
DE102006043443A1 (de) * 2006-09-15 2008-03-27 Bayer Healthcare Ag Neue aza-bicyclische Verbindungen und ihre Verwendung
GB2467670B (en) 2007-10-04 2012-08-01 Intellikine Inc Chemical entities and therapeutic uses thereof
ES2647163T3 (es) 2008-01-04 2017-12-19 Intellikine, Inc. Derivados de isoquinolinona sustituidos con una purina útiles como inhibidores de la PI3K
US8193182B2 (en) 2008-01-04 2012-06-05 Intellikine, Inc. Substituted isoquinolin-1(2H)-ones, and methods of use thereof
US8993580B2 (en) 2008-03-14 2015-03-31 Intellikine Llc Benzothiazole kinase inhibitors and methods of use
EP2252293B1 (fr) 2008-03-14 2018-06-27 Intellikine, LLC Inhibiteurs de kinases, et procédés d utilisation associés
WO2010006072A2 (fr) 2008-07-08 2010-01-14 The Regents Of The University Of California Modulateurs de mtor et leurs utilisations
KR20110039326A (ko) 2008-07-08 2011-04-15 인텔리카인, 인크. 키나제 억제제 및 사용 방법
DE102008041214A1 (de) 2008-08-13 2010-02-18 Bayer Cropscience Ag N-substituierte Azinylakyl-azincarboxamide und deren Analoge
CA2738429C (fr) 2008-09-26 2016-10-25 Intellikine, Inc. Inhibiteurs heterocycliques de kinases
JP5819195B2 (ja) 2008-10-16 2015-11-18 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 融合環ヘテロアリールキナーゼ阻害剤
US8476431B2 (en) 2008-11-03 2013-07-02 Itellikine LLC Benzoxazole kinase inhibitors and methods of use
EP2427195B1 (fr) 2009-05-07 2019-05-01 Intellikine, LLC Composés hétérocycliques et leurs utilisations
GEP201706639B (en) 2009-08-17 2017-03-27 Intellikine Llc Heterocyclic compounds and uses thereof
US8980899B2 (en) 2009-10-16 2015-03-17 The Regents Of The University Of California Methods of inhibiting Ire1
CN102970867A (zh) 2010-03-18 2013-03-13 拜耳知识产权有限责任公司 作为活性剂对抗非生物植物应激的芳基和杂芳基磺酰胺
AU2011255218B2 (en) 2010-05-21 2015-03-12 Infinity Pharmaceuticals, Inc. Chemical compounds, compositions and methods for kinase modulation
JP2013543480A (ja) 2010-10-18 2013-12-05 ラクオリア創薬株式会社 Ｔｔｘ−ｓ遮断薬としてのアリールアミド誘導体
EP2637669A4 (fr) 2010-11-10 2014-04-02 Infinity Pharmaceuticals Inc Composés hétérocycliques et utilisations de ceux-ci
CA2824197C (fr) 2011-01-10 2020-02-25 Michael Martin Procedes de preparation d'isoquinolinones et de formes solides d'isoquinolinones
TWI592411B (zh) 2011-02-23 2017-07-21 英特爾立秦有限責任公司 激酶抑制劑之組合及其用途
EA201490152A1 (ru) 2011-06-24 2014-05-30 Эмджен Инк. Антагонисты trpm8 и их применение при лечении
WO2012177896A1 (fr) 2011-06-24 2012-12-27 Amgen Inc. Antagonistes de trpm8 et leur utilisation dans le cadre thérapeutique
JP6027611B2 (ja) 2011-07-19 2016-11-16 インフィニティー ファーマシューティカルズ， インコーポレイテッド 複素環式化合物及びその使用
AU2012284088B2 (en) 2011-07-19 2015-10-08 Infinity Pharmaceuticals Inc. Heterocyclic compounds and uses thereof
CA2846431A1 (fr) 2011-08-29 2013-03-07 Infinity Pharmaceuticals Inc. Composes heterocycliques et leurs utilisations
JP6342805B2 (ja) 2011-09-02 2018-06-13 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 置換ピラゾロ［３，４−ｄ］ピリミジンおよびその用途
US8940742B2 (en) 2012-04-10 2015-01-27 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
US8828998B2 (en) 2012-06-25 2014-09-09 Infinity Pharmaceuticals, Inc. Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors
US8952009B2 (en) 2012-08-06 2015-02-10 Amgen Inc. Chroman derivatives as TRPM8 inhibitors
MX2015003874A (es) 2012-09-26 2015-12-16 Univ California Modulacion de ire1.
US9481667B2 (en) 2013-03-15 2016-11-01 Infinity Pharmaceuticals, Inc. Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
CN103351348A (zh) * 2013-07-15 2013-10-16 黄河三角洲京博化工研究院有限公司 一种2-甲胺基嘧啶盐酸盐的合成方法
US9751888B2 (en) 2013-10-04 2017-09-05 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
US9359365B2 (en) 2013-10-04 2016-06-07 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
CA2943075C (fr) 2014-03-19 2023-02-28 Infinity Pharmaceuticals, Inc. Composes heterocycliques destines a etre utilises dans le traitement de troubles medies par pi3k-gamma
WO2015160975A2 (fr) 2014-04-16 2015-10-22 Infinity Pharmaceuticals, Inc. Polythérapies
US9708348B2 (en) 2014-10-03 2017-07-18 Infinity Pharmaceuticals, Inc. Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereof
NZ740616A (en) 2015-09-14 2023-05-26 Infinity Pharmaceuticals Inc Solid forms of isoquinolinone derivatives, process of making, compositions comprising, and methods of using the same
WO2017161116A1 (fr) 2016-03-17 2017-09-21 Infinity Pharmaceuticals, Inc. Isotopologues de composés isoquinolinone et quinazolinone et leurs utilisations comme inhibiteurs de la kinase pi3k
US10919914B2 (en) 2016-06-08 2021-02-16 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
MX2018016227A (es) 2016-06-24 2019-07-08 Infinity Pharmaceuticals Inc Terapias de combinacion.

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4555573A (en) * 1983-11-15 1985-11-26 Riker Laboratories, Inc. Certain 6-benzamidomethyl-2(1H)-pyridone derivatives
AR241530A1 (es) * 1984-12-21 1992-08-31 Ciba Geigy A G Cesionaria De F 1,2,4-triazoles, composicion para el control de pestes y procedimiento para la preparacion de 1,2,4-triazoles.
US4931561A (en) * 1987-07-29 1990-06-05 Koei Chemical Co., Ltd. Process for preparing nitriles
EP0361791B1 (fr) * 1988-09-26 1995-11-08 Smithkline Beecham Farmaceutici S.p.A. Composés azacycliques, utiles commes médicaments
DE4019420A1 (de) * 1990-06-19 1992-01-02 Bayer Ag Polycyanopyrimidine und verfahren zu ihrer herstellung
US5656253A (en) * 1990-09-14 1997-08-12 Mallinckrodt Medical, Inc. Ligands useful in radiographic imaging
JP2994182B2 (ja) * 1992-07-23 1999-12-27 石原産業株式会社 アミド系化合物又はその塩、それらの製造方法及びそれらを含有する有害動物防除剤
MX9304801A (es) * 1992-08-06 1997-06-28 Warner Lambert Co 2-toindoles (selenoidoles) disulfuros (seleniduros) relacinados, los cuales inhiben a las proteinas tirosina cinasas y los cuales tienen propiedades anti-tumorales.
CZ283965B6 (cs) * 1992-08-06 1998-07-15 Warner-Lambert Company 2-thioindolové, 2-indolinthionové a polysulfidové sloučeniny, 2-selenoindolové, 2-indolinselenonové a selenidové sloučeniny a farmaceutické prostředky na jejich bázi
JP3694051B2 (ja) * 1994-07-12 2005-09-14 バイエルクロップサイエンス株式会社 １−ピリジルテトラゾリノン誘導体および除草剤
EA002767B1 (ru) * 1995-02-10 2002-08-29 Басф Акциенгезельшафт Ингибиторы тромбина
GB9510459D0 (en) * 1995-05-24 1995-07-19 Zeneca Ltd Bicyclic amines
US5883254A (en) * 1996-11-08 1999-03-16 Hoffmann-La Roche Inc. Process for making pyrimidine derivatives
EP0944627B1 (fr) * 1996-11-26 2004-02-18 Syngenta Limited Derives de 8-azabicyclo 3.2.1.]octane-, 8-azabicyclo 3.2.1]oct-6-ene-, 9-azabicyclo 3.3.1]nonane-, 9-aza-3-oxabicyclo 3.3.1]nonane- et 9-aza-3-thiabicyclo 3.3.1]nonane, leur preparation et leur utilisation comme insecticides
GB9624611D0 (en) * 1996-11-26 1997-01-15 Zeneca Ltd Bicyclic amine compounds
DE19725450A1 (de) * 1997-06-16 1998-12-17 Hoechst Schering Agrevo Gmbh 4-Haloalkyl-3-heterocyclylpyridine und 4-Haloalkyl-5-heterocyclylpyrimidine, Verfahren zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung als Schädlingsbekämpfungsmittel
DE19858193A1 (de) * 1998-12-17 2000-06-21 Aventis Cropscience Gmbh 4-Trifluormethyl-3-oxadiazolylpyridine, Verfahren zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung als Schädlingsbekämpfungsmittel
WO2000012564A1 (fr) * 1998-08-31 2000-03-09 Nof Corporation Polysaccharide a haut degre de purete contenant des groupes hydrophobes et procede de production de ce polysaccharide
ES2244214T3 (es) * 1998-09-15 2005-12-01 Syngenta Participations Ag Piridincetonas utiles como herbicidas.
ES2300151T3 (es) * 1998-09-22 2008-06-01 Astellas Pharma Inc. Derivados de cianofenilo.
DE19858192A1 (de) * 1998-12-17 2000-06-21 Aventis Cropscience Gmbh 4-Trifluormethyl-3-oxazolylpyridine, Verfahren zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung als Schädlingsbekämpfungsmittel
AU5451400A (en) * 1999-06-04 2000-12-28 Merck & Co., Inc. Thrombin inhibitors
UA58636C2 (uk) * 1999-06-04 2003-08-15 Мерк Енд Ко., Інк. Піразинонові інгібітори тромбіну, фармацевтична композиція, спосіб інгібування утворення тромбів у крові, спосіб лікування станів, пов'язаних із тромбоутворенням
GB9919588D0 (en) * 1999-08-18 1999-10-20 Hoechst Schering Agrevo Gmbh Fungicidal compounds
BR0013438A (pt) * 1999-08-20 2002-04-30 Syngenta Participations Ag Derivados de trifluorometilpiri(mi)dina
KR20020047198A (ko) * 1999-09-30 2002-06-21 해피 페너 ; 해리 에이치. 페너 2세 특정 알킬렌 디아민-치환된피라졸로[1,5-ａ]-1,5-피리미딘 및피라졸로[1,5-ａ]-1,3,5-트리아진
AU2044401A (en) * 1999-11-23 2001-06-04 Merck & Co., Inc. Pyrazinone thrombin inhibitors
AU3740101A (en) * 2000-03-01 2001-09-12 Janssen Pharmaceutica Nv 2,4-disubstituted thiazolyl derivatives
EP1274683A2 (fr) * 2000-03-22 2003-01-15 Bayer CropScience GmbH Acylsulfimides heterocycliques, leur procede de preparation, substances les contenant, et leur utilisation en tant qu'agent de lutte contre les parasites
DE10039477A1 (de) * 2000-08-08 2002-02-21 Aventis Cropscience Gmbh Heterocyclylalkylazol-Derivate und ihre Verwendung als Schädlingsbekämpfungsmittel
RU2003110962A (ru) * 2000-09-18 2004-10-20 Е.И.Дюпон де Немур энд Компани (US) Пиридиниламиды и имиды для использования в качестве фунгицидов
AU2002366027B2 (en) * 2001-11-21 2007-10-25 Sankyo Agro Company, Limited N-heteroarylnicotinamide derivatives
SE0104140D0 (sv) * 2001-12-07 2001-12-07 Astrazeneca Ab Novel Compounds
ES2271442T3 (es) * 2002-08-22 2007-04-16 Honeywell Normalair-Garrett (Holdings) Limited Metodo para ionstalar un sistema de enriquesimiento con gas de lecho de tamiz molecular.
US7150550B2 (en) * 2004-09-29 2006-12-19 Lear Corporation Automotive map pocket having an electroluminescent lamp and method of making the same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2005113553A2 *

Also Published As

Publication number Publication date
CA2566074A1 (fr) 2005-12-01
KR20070033980A (ko) 2007-03-27
DE102004022897A1 (de) 2005-12-08
BRPI0511025A (pt) 2007-11-27
MXPA06013135A (es) 2007-02-28
WO2005113553A2 (fr) 2005-12-01
EA200602038A1 (ru) 2007-04-27
ZA200609252B (en) 2008-06-25
WO2005113553A3 (fr) 2006-01-05
TW200607451A (en) 2006-03-01
JP2007536307A (ja) 2007-12-13
US20080293674A1 (en) 2008-11-27
CN1980926A (zh) 2007-06-13

Similar Documents

Publication Publication Date Title
EP1751152A2 (fr) Imidazoazines d'azinyle et carboxamides d'azinyle
DE19603576A1 (de) Acylierte 4-Amino und 4-Hydrazinopyrimidine
DE10320782A1 (de) Substituierte Oxyarene
DE10360369A1 (de) Amide
DE102004031323A1 (de) Substituierte Pyridazincarboxamide und Derivate hiervon
WO2005097802A1 (fr) Derives de quinoleine anneles comme pesticides
WO2004026858A1 (fr) Heterocyclylpyrimidines substituees
EP1572663B1 (fr) Biphenylcarboxamides
DE10301519A1 (de) 9-Ketospinosyn-Derivate
DE10357567A1 (de) Pyrazolopyrimidine
DE10357568A1 (de) Pyrazolopyrimidine
DE102004007076A1 (de) Imidazolopyrimidine
EP1569909B1 (fr) Pyrazoline-carboxanilides substitues utilises comme pesticides
EP1537101A1 (fr) Derives de tetrahydropyridazine a effet pesticide
DE10339360A1 (de) Pyrazolopyrimidine
DE102004056626A1 (de) Substituierte Oxyguanidine
DE102004034867A1 (de) Substituierte 1H-Pyrrol-2,5-dione
DE19624603A1 (de) Verwendung von Pyrrolopyrimidinen zur Bekämpfung von Schädlingen
DE10357566A1 (de) Pyrazolopyrimidine
DE10359074A1 (de) Pyrazolinole
DE102004013528A1 (de) Heterocyclische Spirocyclopropylverbindungen
DE10357570A1 (de) Pyrazolopyrimidine

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20061211

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20080404

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20081015